Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company
PITTSBURGH, Sept. 21 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises, announced today that one of its nationally recognized Executives-in-Residence (EIR) has launched a new medical device company; Intimate Bridge to Conception, Inc. (Ib2C(TM)).
Ib2C(TM) Founder and CEO, Stephen Bollinger was recruited back to Pittsburgh in 2009 after 26 years away to join the PLSG as an EIR. Since that time, Steve has assisted seventeen regional medical device companies while also working on the formation and development of Ib2C(TM)'s commercialization pathway.
Intimate Bridge to Conception, Inc. is an early-stage medical device company focused on reproductive health to aid in natural fertility and conception in the privacy of the patient's home. Ib2C(TM) gives women and couples healthcare products that will assist them in reaching their reproductive goals. Ib2C(TM) will have a positive impact and a positive effect in two targeted populations; individuals committed to building a family and patients diagnosed with infertility that have not been able to participate or have been unsuccessfully served by current fertility alternatives.
"We have great confidence in Steve's leadership," said John W. Manzetti, PLSG President & CEO. "His talent and drive, as well as his experience and knowledge of the medical devices industry will allow for a strong launch for Ib2C(TM) and his vision will set the stage for a strong future for the company." Mr. Manzetti continued, "Steve is a perfect example of the success of the PLSG's Executive Program and our efforts to attract and keep C-level life sciences talent in our region."
In the growing era of infertility, currently one in six women are looking for help becoming pregnant. This population has very few options and most of the availa